Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Lisinopril and Labetalol on Baroreflex Sensitivity in Stroke
2004-004231-53Phase 4Completed
- Sponsor
- Royal Devon University Healthcare NHS Foundation Trust
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lisinopril and labetalol in stroke and cerebrovascular disease, sponsored by Royal Devon University Healthcare NHS Foundation Trust. Primary endpoint: Change in baroreflex sensitivity. Started Feb 2005; status: completed.
02
Drugs
lisinoprillabetalol
03
Conditions
strokecerebrovascular disease
Beyond the preview
Go deeper on 2004-004231-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004231-53.